학술논문
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study
Document Type
Article
Author
Source
In: Haematologica . (Haematologica, February 2024, 109(2):553-566)
Subject
Language
English
ISSN
15928721
03906078
03906078